Author

Mark Berner-Hansen 1

1 Astra Zeneca R&D,Mölndal,Sweden

A COMPUTATIONAL APPROACH TO GENOTYPE-DRIVEN DRUG REPOSITIONING IN INFLAMMATORY BOWEL DISEASE (IBD)

Ferdinando Bonfiglio, Tahmina Akhter, Anna Reznichenko, Jonas Halfvarson, Kristian Sandberg, Mark Berner-Hansen, Andre Franke, Dario Greco, Mauro D'Amato

ACUTE INTESTINOTROPHIC EFFECTS OF SHORT AND LONG-ACTING GLP-2 ANALOGUES IN RATS

Jolanta Skarbaliene, Mark Berner-Hansen

ALTERED EXPRESSION OF ACETYLCHOLINE RELATED PROTEINS IN NORMAL COLONIC MUCOSA FROM PATIENTS WITH COLORECTAL NEOPLASIA

Morten Matthiesen Bach Damm, Thorbjørn Søren Rønn Jensen, Badar Mahmood, Morten Lundh, Svend Knuhtsen, Niels Bindslev, Mark Berner-Hansen

ALTERED TUFT CELL POPULATION OF HUMAN COLONIC EPITHELIUM IN INFLAMMATORY BOWEL DISEASES

Thorbjørn Søren Rønn Jensen, Sebastian Kjærgaard, Ulrike Ries Feddersen, Steen Seier Poulsen, Kaare Villum Grunddal, Mark Berner-Hansen, Niels Bindslev

GEOGRAPHIC EVOLUTION OF PEDIATRIC INTESTINAL FAILURE (PIF) MANAGEMENT IN THE UNITED STATES (US)

David F Mercer, Kishore Iyer, Daniel Pfeffer, Lis Brøsted Zimmermann, Mark Berner-Hansen, Manpreet Mundi, Douglas L. Seidner

GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOGUE, EXPOSURE DOES NOT CORRELATE WITH HEPATIC INDOCYANINE GREEN CLEARANCE

Kim Sonne, Mikkel Askjær Agersnap, Birgitte Biilmann Rønn, Mark Berner-Hansen, Rahim Naimi, Mark Krogh Hvistendahl, Rikard Ambrus, Nikolaj Albeck Nerup, Lars Bo Svendsen, Palle Bekker Jeppesen

NANOMOLAR EP4 RECEPTOR POTENCY IN NORMAL APPEARING COLONIC MUCOSA FROM PATIENTS WITH COLORECTAL NEOPLASIA

Ulrike Ries Feddersen, Sebastian Kjærgaard, Mark Alexander Berner-Hansen, Thomas Andrew Jepps, Mark Berner-Hansen, Niels Bindslev

THE NOVEL DUAL GLP-1 AND GLP-2 RECEPTOR AGONIST DAPIGLUTIDE ATTENUATES INTESTINAL INSUFFICIENCY IN A MURINE SHORT BOWEL MODEL

Jolanta Skarbaliene, Peggy Berlin, Jascha Held, Jonathan Griffin, Per-Olof Eriksson, Mark Berner-Hansen, Robert Jaster, Wayne Russell, Maria Witte, Georg Lamprecht, Johannes Reiner, Johanna Thiery

THE ROLE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS AN EARLY BIOMARKER OF SEVERITY AND ORGAN FAILURE IN PATIENTS WITH ACUTE PANCREATITIS

Amir Soleimani, Lars Tue Sørensen, Mark Berner-Hansen, Steen Ladelund, Jesper Eugen-Olsen, Lars Nannestad Jorgensen, Srdan Novovic

THERAPEUTIC POTENTIAL OF GLEPAGLUTIDE, A LONG-ACTING GLUCAGON-LIKE PEPTIDE-2 RECEPTOR AGONIST, IN A RAT MODEL OF RECURRENT INDOMETHACIN-INDUCED SMALL INTESTINAL INFLAMMATION

Jolanta Skarbaliene, Christian Thorkildsen, Mark Berner-Hansen, Wayne Russell

Item 1 - 10 / 13
1
2